|
Model system | Number of miRNAs screened | Type of regulation | Phenotype measured | Assay | Year | Reference |
|
HeLa and A549 | 95 | Loss-of-function by miRNA inhibitors | Cell proliferation and apoptosis | Cell counting and caspase-3/7 activity assay | 2005 | [100] |
|
Primary hTERT-immortalized BJ-EHT fibroblasts | ~450 | Gain-of-function by stable miRNA expression | Sustained proliferation | miR-Array | 2006 | [40] |
|
HeLa | ~450 | Gain-of-function by stable miRNA expression | p27Kip1 regulation | GFP reporter assay and miR-Array | 2007 | [45] |
|
MDA-MB-453 | 187 | Gain-of-function by miRNA precursors | TRAIL-induced caspase-3 activation | Caspase-3/7 activity assay | 2007 | [104] |
|
Drosophila clone 8 cells | 77/78 miRNA loci | Gain-of-function by plasmid-based miRNA expression | Wg signaling pathway regulation | Luciferase reporter assay | 2007 | [110] |
|
Neuroblastoma cell lines | 8 | Gain- and loss-of-function by miRNA mimics and inhibitors | Proliferation | Change in electrical impedance | 2008 | [111] |
|
MCF7 | ~450 | Gain-of-function by stable miRNA expression | Cell migration | Trans-well cell migration assay | 2008 | [101] |
|
HeLa | 91 | Gain-of-function by miRNA mimics | p53 gene activity | Luciferase reporter assay | 2009 | [38] |
|
HeLa | ~450 | Gain-of-function by stable miRNA expression | Per gene family regulation | GFP reporter assay and miR-Array | 2009 | [102] |
|
Primary ovarian granulosa cells | 80 | Gain-of-function by miRNA precursors | Progesterone, testosterone and estradiol release | Enzyme immunoassay (EIA) | 2009 | [112] |
|
HEK 293 | 266 | Gain-of-function by miRNA mimics | p21Cip/Waf1 regulation | Luciferase reporter assay | 2010 | [46] |
|
HCT-16 | 810 | Gain-of-function by miRNA mimics | Cell viability in the presence of Bcl-2 family inhibitor ABT-263 | CellTiter-Glo Luminescent Cell Viability Assay | 2010 | [99] |
|
HEK 293T | 107 | Gain-of-function by miRNA mimics | p53 gene regulation | Luciferase reporter assay | 2010 | [39] |
|
HCT116 p53+/+, H460 and MCF7 | 5 | Gain-of-function by miRNA precursors | p53 gene regulation | Western blot | 2010 | [10] |
|
Huh-7 | 327 | Gain-of-function by miRNA precursors | Lipid droplet formation and growth | Immunocytochemistry and fluorescence microscopy | 2010 | [105] |
|
Primary ovarian granulosa cells | 80 | Gain-of-function by miRNA precursors | Proliferation and apoptosis | Immunocytochemistry and fluorescence microscopy | 2010 | [113] |
|
DLD-1 | 319 | Gain-of-function by miRNA precursors | Cell viability | CellTiter-Glo Luminescent Cell Viability Assay | 2010 | [11] |
|
HMEC | 328 | Gain-of-function by miRNA precursors | Proliferation | Fluorescence microscopy | 2010 | [114] |
|
MIA PaCa-2 | 445 | Gain-of-function by stable miRNA expression | Proliferation | Custom-made microarray | 2010 | [115] |
|
HeLa and HeLa P4 | 8 | Gain- and loss-of-function by miRNA precursors and inhibitors | Cell proliferation and trafficking | Fluorescence microscopy | 2011 | [116] |
|